This is an AI generated summary. There may be inaccuracies. · The green links below are Amazon affiliate links where summarize.tech may earn a commission.
Summarize another video · Purchase summarize.tech Premium
In the YouTube video "Médicos alertam para os risks da automedicação com uso de injeções emagrecedoras" (Doctors warn about the risks of self-medication with weight loss injections), the speaker discusses the use of Ozempic, a diabetes medication repurposed for weight loss, and the risks associated with self-medication. Diego, a man who used Ozempic for weight loss for about a year, shares his surprising results. However, doctors caution against using Ozempic for weight loss of less than 3-4 kg and warn of increased side effects with self-medication. The video also mentions the high demand for Ozempic, leading to shortages and increased profits for the manufacturer. The authorization of another injectable medication, Monaro, for obesity treatment is also touched upon, but it's not yet available in Brazil. The speaker emphasizes the distinction between "emagrecedor" (weight loss medication) and "medicine" for treating obesity.
Copyright © 2024 Summarize, LLC. All rights reserved. · Terms of Service · Privacy Policy · As an Amazon Associate, summarize.tech earns from qualifying purchases.